Full-Time

Medical Science Liaison

Multiple Teams

Posted on 9/12/2025

Amplity

Amplity

1-10 employees

Global contract services for drug lifecycle

Compensation Overview

$195k - $208k/yr

Newport Beach, CA, USA + 5 more

More locations: San Francisco, CA, USA | Los Angeles, CA, USA | Irvine, CA, USA | Anaheim, CA, USA | San Diego, CA, USA

Remote

Candidates should be based in California as the role requires weekly travel within the designated region.

Category
Medical, Clinical & Veterinary (1)
Requirements
  • Degree from an accredited university or college required.
  • Individuals with Pharm D, Ph.D, MSN, NP, RN with relevant clinical backgrounds and pharmaceutical field experience
  • Pharmaceutical experience required in an MSL/MSL like role.
  • Knowledge of regulatory requirements and the ability to ensure compliance in all activities.
  • Proficiency in Microsoft Office Suite and other relevant software.
  • Must pass all product and compliance training.
  • Valid driving license with a safe driving record.
Responsibilities
  • Engage in detailed clinical discussions with Nephrologists, Endocrinologists, and Cardiologists healthcare professionals to provide scientific insights on the importance of vaccines for preventable diseases.
  • Health system mapping
  • Have a deep understanding of healthcare systems, including their complexities and operational dynamics, to effectively communicate and collaborate with healthcare professionals.
  • Build and maintain relationships with key opinion leaders (KOLs) and healthcare professionals within the region.
  • Travel a weekly basis within the region and to attend conferences and meetings.
  • Provide scientific support to internal teams, to ensure accurate and effective communication of scientific information.
  • Ensure all activities are conducted in compliance with regulatory and company policies.
Desired Qualifications
  • Experience in cardiology, nephrology and or endocrinology desired.
  • Recognition of the role of vaccines in the management of treatable diseases.
  • Effective synthesizing, interpreting and distilling large quantities of clinical to key stakeholders and HCPs.
  • Capable of managing time efficiently allocating and prioritizing tasks to achieve goals promptly and effectively.
  • Adept navigating complex health systems and ecosystems.
  • Understanding of vaccines and their importance in various therapeutic areas.
  • Willingness to travel weekly within region and nationally for meetings.

Amplity Health provides medical and commercial outsourcing services to pharmaceutical and healthcare companies across the full drug lifecycle. It uses an AI-driven platform and a HIPAA-compliant database to turn data into insights, while offering contract Medical Science Liaisons and patient support teams to engage with healthcare providers. The company combines data analytics, hands-on medical affairs execution, and a flexible, contract-based workforce to help clients scale as needed. Its goal is to speed up drug development, approvals, and market access while ensuring compliant data handling and efficient resource use.

Company Size

1-10

Company Stage

Debt Financing

Total Funding

$102.5M

Headquarters

Santa Cruz, California

Founded

2010

Simplify Jobs

Simplify's Take

What believers are saying

  • Christina DiBiase's April 2026 CEO appointment drives growth with 17 years experience.
  • Lynx Group 2022 acquisition expands medical communications and omnichannel marketing.
  • 40-year legacy specializes in oncology, rare diseases across 60 countries.

What critics are saying

  • IQVIA's 2025 IPM.ai acquisition erodes Amplity's oncology insights dominance.
  • FDA April 2026 AI guidance halts Ava and AskX deployments by 2027.
  • Ashfield poaches 15% of Amplity's oncology MSLs since January 2026.

What makes Amplity unique

  • Amplity Insights™ analyzes 70 million doctor-patient records to reveal treatment decision 'whys'.
  • In Practice platform delivers oncology intelligence for community oncologists since 2026.
  • Ava AI chatbot enhances personalized digital experiences on Amplity.com.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Unlimited Paid Time Off

Company News

The News Courier
Mar 26th, 2026
Peritia appoints Michael A. Griffith as Chief Executive Officer.

Peritia appoints Michael A. Griffith as Chief Executive Officer. PR Newswire Today at 4:00am PDT Veteran life sciences executive and platform builder brings decades of biopharma leadership to accelerate growth. MORRISVILLE, N.C. and NEW YORK, March 26, 2026 /PRNewswire/ - Peritia, a global biopharmaceutical and medtech consulting company with deep expertise in clinical development and value and evidence generation, today announced the appointment of Michael Griffith as Chief Executive Officer. Mr. Griffith brings more than 25 years of executive leadership experience to build and scale global pharmaceutical services businesses, and his appointment marks a significant milestone in Peritia's evolution. A Platform Builder with Proven Impact Most recently, Mike served as founder and CEO of Amplity Health, a global contract medical and commercial organization operating across 40 countries with more than 1,000 colleagues. Prior to Amplity, he served as Operating Partner at Altamont Capital Partners, where he led investments in biopharmaceutical outsourcing businesses, and as President of the Commercial Division of inVentiv Health, a leading global provider of biopharmaceutical outsourcing services across the research and commercialization continuum. His career also includes CEO stints at ChiRex, Aptuit, and Laureate Biopharma - each a recognized leader in contract drug development and manufacturing - as well as board service at Repligen Corporation and other public life sciences companies. He holds a Master of Management degree from Northwestern University's Kellogg School of Management. "As biopharma and medtech innovator funding continues to build, Peritia is exactly the kind of platform the industry needs right now - one that combines scientific depth, strategic advisory, and operational capability to our client engagements," said Mike Griffith. Peritia has successfully completed more than 1,100 engagements in 20 countries for 355 clients in the past five years. "Now we have the opportunity to scale the enterprise with purpose by building on the strong foundation that's already been established. Our goal is to be a trusted partner for biotech, pharma, and medtech innovators who require additional power to navigate clinical development and health economics." Griffith's appointment comes on the heels of Peritia's formal rebranding and consolidation of BioBridges, CHEORS, and Monitorforhire into a unified platform spanning corporate and product strategy, operational execution, and value, evidence, and access. His track record of building high-performance cultures and scaling life sciences service organizations positions him to accelerate Peritia's mission of guiding life sciences organizations from concept to commercialization. For media inquiries or to learn more about how Peritia can support your programs, please contact us at us at [email protected] or visit www.peritia.com, or visit our LinkedIn page at https://www.linkedin.com/company/peritiaholdings/ About Peritia Peritia is a global biopharmaceutical and medtech consulting company specializing in clinical development and value and evidence generation. We connect industry-leading talent with organizations across the life sciences ecosystem to help bring innovations to patients efficiently and effectively. In the last five years, Peritia has completed more than 1,100 engagements for 335 clients worldwide. Peritia \puh-rish-uh\ noun: the state or quality of being experienced. SOURCE Peritia This is a paid placement. For further inquiries, please contact PR Newswire directly.

Amplity
Jul 10th, 2025
Amplity Rebrand Earns Prestigious Industry Awards

The Titan Awards, an international advertising competition recognizing extraordinary achievements in healthcare advertising and marketing, honored Amplity as a Platinum Winner for Best Rebranding Effort and a Gold Winner for Best Website Design.

PR Newswire
Jun 1st, 2025
The Academy Of Oncology Nurse Patient Navigators And Gilead Sciences Partner To Launch Oncology Navigation Grant Program

GAINESVILLE, Fla., June 1, 2025 /PRNewswire/ -- The Academy of Oncology Nurse & Patient Navigators (AONN+) is proud to announce the launch of a groundbreaking grant program in partnership with Gilead Sciences aimed at advancing the field of oncology navigation and enhancing patient outcomes within the healthcare setting. This initiative is designed to support the creation, enhancement, and expansion of innovative tools that optimize efficiency and elevate the critical role of oncology navigators.Following the AONN+ call for grant submissions in April, healthcare leaders across the country responded with creative applications, software solution ideas and healthcare system improvements. AONN+ looks to announce the recipients of the award, valued up to $500,000, in June with project work to begin in the July time frame. The AONN+ grant application process and implementation support for awardees also included help from Amplity, AONN+'s association management partner and strategic collaborator."Through this funding mechanism, AONN+ and Gilead are committed to addressing persistent challenges in cancer care by empowering navigators to play a pivotal role in improving patient access to navigation services, removing barriers to cancer care, and supporting treatment adherence," says Candice Roth, MSN, RN, CENP, Executive Director, AONN+. "Navigator utilization continues to present significant opportunities for optimizing patient outcomes, and this program seeks to provide impactful solutions that directly tie proposed tools to measurable improvements in patient care.""As part of Gilead's Community Cancer Collective, we are proud to partner with AONN+ on this exciting initiative in support of the oncology community," said Darren Tayama, M.D., Vice President, US Medical Affairs, Oncology. "Together, AONN+ and Gilead are advancing the future of cancer care through innovative solutions in oncology navigation."About the Academy of Oncology Nurse & Patient Navigators , Inc

Amplity
May 28th, 2025
Meet Ava: Amplity's AI Chatbot Enhancing Web UX

Amplity, a full-service partner for outsourcing flexible medical and commercial services, proudly announces the launch of Ava, an AI-powered chatbot designed to deliver faster, more personalized digital experiences on Amplity.com.

Amplity
May 15th, 2025
Amplity Unveils GLP-1 RAs & Biologic Trends At ISPOR 2025

Amplity unveils GLP-1 RAs & biologic trends at ISPOR 2025.

INACTIVE